Parabilis Medicines
Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced a novel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Domain
parabilismed.com
Country
United StatesIndustry
BiopharmaEmployees
101-250
Last Funding
$305.0M
Founded
2015
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does Parabilis Medicines use?+
Parabilis Medicines uses 16 technologies including Font Awesome, Google Analytics, Google Tag Manager.
What industry is Parabilis Medicines in?+
Parabilis Medicines operates in the Biopharma industry.
Where is Parabilis Medicines based?+
Parabilis Medicines is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026